These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12113282)

  • 1. Guidelines: more patients should get lipid screenings.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 May; 12(9):9-10, 12. PubMed ID: 12113282
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for lipid disorders in adults: recommendations and rationale.
    Am Fam Physician; 2002 Jan; 65(2):273-6. PubMed ID: 11820491
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening adults for lipid disorders: recommendations and rationale.
    US Preventive Services Task Force
    Am J Prev Med; 2001 Apr; 20(3 Suppl):73-6. PubMed ID: 11306235
    [No Abstract]   [Full Text] [Related]  

  • 4. U.S. Preventive Services Task Force: screening for lipid disorders in adults: recommendations and rationale.
    Berg AO; Atkins D;
    Am J Nurs; 2002 Jun; 102(6):91, 93, 95. PubMed ID: 12394084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Social committee on cholesterol: new guidelines for improved data findings].
    Beermann B; Leppert J; Lithell H; Vessby B
    Lakartidningen; 1989 Apr; 86(16):1458. PubMed ID: 2725126
    [No Abstract]   [Full Text] [Related]  

  • 6. His and hers checklists for health.
    Dirks F
    Am J Nurs; 2007 Oct; 107(10):33. PubMed ID: 17895724
    [No Abstract]   [Full Text] [Related]  

  • 7. USPSTF scales back approach to lipid screening for women.
    Campos-Outcalt D
    J Fam Pract; 2008 Nov; 57(11):740-2. PubMed ID: 19006623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dyslipoproteinemia and vascular injury].
    Saitta A; Cinquegrani M; Nania G; Pangallo A; Rulli N; Squadrito F; Totaro S; Squadrito G
    Cardiologia; 1983 Aug; 28(8):695-720. PubMed ID: 6687212
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol guidelines: physicians must determine risks more precisely.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(12):1-2, 5. PubMed ID: 12166450
    [No Abstract]   [Full Text] [Related]  

  • 10. An assessment of the new lipid screening guidelines.
    Steiner MJ; Brown WD; Liles E
    Pediatrics; 2008 Oct; 122(4):904-5; author reply 906-7. PubMed ID: 18829821
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE).
    Foody JM; Roe MT; Chen AY; Smith SC; Brindis RG; Peterson ED; Gibler WB; Ohman EM;
    Am J Cardiol; 2005 Feb; 95(4):483-5. PubMed ID: 15695133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' perception of guideline-recommended low-density lipoprotein target values: characteristics of misclassified patients.
    Sager HB; Linsel-Nitschke P; Mayer B; Lieb W; Franzel B; Elsasser U; Schunkert H
    Eur Heart J; 2010 May; 31(10):1266-73. PubMed ID: 20219745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina.
    Bertoni AG; Bonds DE; Steffes S; Jackson E; Crago L; Balasubramanyam A; Chen H; Goff DC
    Am Heart J; 2006 Oct; 152(4):785-92. PubMed ID: 16996859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia prevalence in a laboratory initiated screening program.
    Emerson JF; Jafari M
    Clin Lab Sci; 2002; 15(2):67-70. PubMed ID: 12776768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
    Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
    Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel idea in BPH guideline: the patient as decision maker.
    Roberts RG
    Am Fam Physician; 1994 Apr; 49(5):1044-6, 1051. PubMed ID: 7512307
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of hyperlipidemias].
    Lageder H; Irsigler K; Bischof M; Denck H
    Acta Med Austriaca Suppl; 1977; (4):88. PubMed ID: 199025
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary on: 'Screening for lipid disorders in adults: recommendation and rationale'.
    Lloyd M
    Am J Nurs; 2002 Jun; 102(6):96. PubMed ID: 12394085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.